scholarly journals Young patients with heart failure: clinical characteristics and outcomes. Data from the Swedish Heart Failure, National Patient, Population and Cause of Death Registers

2020 ◽  
Vol 22 (7) ◽  
pp. 1125-1132
Author(s):  
Carmen Basic ◽  
Annika Rosengren ◽  
Urban Alehagen ◽  
Ulf Dahlström ◽  
Magnus Edner ◽  
...  
2019 ◽  
Vol 40 (Supplement_1) ◽  
Author(s):  
C Basic ◽  
A Rosengren ◽  
U Dahlstrom ◽  
M Edner ◽  
T Zverkova Sandstrom ◽  
...  

Abstract Background The last two decades incidence and prevalence of heart failure (HF) among young patients have increased in Sweden. Up to the beginning of the 21st century mortality in patients with HF has decreased but causes of death and the effects of co-morbidity on mortality in young patients with HF are not well studied. Purpose To address causes of death and the effect of co-morbidity at baseline on mortality during the last decade in young patients with HF. Methods The Swedish Heart Failure Register (SwedeHF,) a nationwide quality register, was introduced in Sweden in 2003. All hospital discharge diagnoses are recorded in the National Patient Register (NPR) and deaths are registered in the Cause of Death Register. All patients ≥18 and <55 years with a HF diagnosis in SwedeHF were included and linked to the Cause of Death Register and NPR with the personal identification number. ICD 10-codes for all comorbidities and principal cause of death were identified during the observation period from 2003 to 2016. Besides, comorbidity and mortality data were compared with age and sex matched controls from the general population, database from Statistics Sweden (SCB). Results We identified 3752 (6.2%) patients <55 years from the total SwedeHF population (n=60,962) and added 7573 age and sex matched controls. There were 971 (25.9%) women and 2781 (74.1%) men mean age 44.9 (8.4) and 46.4 (7.3) years respectively. Among the young 604 (16.1%) patients died vs. 162 (2.2%) among matched controls (p<0.001) during the observation period. Principal cause of death was HF in 2.7% of the young patients (in men 3% vs. 1.4% in women (p=0.221)), other cardiovascular diseases 48.7% (27.7% in men vs. 20% in women (p=0.05)), congenital heart disease 4% (3% in men vs. 6.9% in women (p=0.077)), cancer 12.9% (9.6% in men vs. 23.6% in women (p=0.003)), neurologic disease 4.5% (5.4% in men vs. 1.4% in women (p=0.028)) suicide 0.8% (0.7% in men vs 1.4% in women (p=0.47)) and other causes 15.1% (15.9% in men vs 12.5% in women (p=0.179)) vs. 0, 26.5%, 1.2%, 32.7%, 1.2%, 9.9% and 18.5% in matched controls (all p<0.0001). The effect of co-morbidity at baseline on mortality in young patients with HF is presented in Figure 1. Effect of co-morbidity on mortality Conclusion Compared to matched controls young patients with HF had worse survival. Almost one quarter of women with HF had cancer as a principal cause of death. Men with AF, obesity and depression at baseline had higher risk to die than women. Women with HF and hypertension, PAH or kidney disease at baseline had higher risk to die than men with HF and the same co-morbidities. Acknowledgement/Funding Swedish state under the agreement concerning research and education of doctors, The Swedish Heart and Lung Foundation, Västra Götaland Region grants


2018 ◽  
Vol 39 (suppl_1) ◽  
Author(s):  
C Basic ◽  
A Rosengren ◽  
U Dahlstrom ◽  
M Edner ◽  
T Zverkova Sandstrom ◽  
...  

2020 ◽  
Vol 41 (Supplement_2) ◽  
Author(s):  
C Basic ◽  
A.R Rosengren A ◽  
U.D Dahlstrom ◽  
M.E Edner ◽  
T.Z.S Zverkova Sandstrom ◽  
...  

Abstract Background There is a lack of data evaluating excess mortality risk (over that of the general population) and life-years lost in young patients with different heart failure (HF) phenotypes. Purpose To study excess risk for all-cause mortality in patients &lt;55 years by their ejection fraction (EF) categories and estimate lost “life years” compared to the general population in Sweden. Methods All patients ≥18 years registered in the national quality register SwedeHF from 2003 to 2014 were included. Patients were divided into ≥55 years and &lt;55 years. For each patient two controls without a HF diagnosis, matched for age, sex and county, were identified from the Swedish Population Register. The use of personal identification number enabled linkage to other registers. All somatic hospital discharge diagnoses are recorded in the National Patient Register (NPR). Time of death and causes of death were obtained from the Cause of Death Register. International Classification of Disease ICD 9 and ICD 10-codes for all co-morbidities were identified in NPR and for underlying causes of death during the observation period from the 1st January 2003 to 31st December 2015. Life expectancy tables from Statistics Sweden were used as reference to the conditional life expectancy for controls calculated at the age 20, 25, 30, 35 and 40 years. Life-years lost were calculated as the difference between conditional life expectancy and conditional survival for patients with HF &lt;55 years presented as median. Results In total 60,962 patients, out of whom 3752 &lt;55 years and 7425 controls &lt;55 years were identified. Total observation time was 12 years; median 4.89 years. There were 2549 (67.9%) patients with ejection fraction (EF) &lt;40% and 357 (9.5%) with EF &gt;50%. Patients with HF&lt;40% were more likely to be men (78.2% vs. 56.3%), to have ischemic heart disease (16.9% vs. 2.3%) and dilated cardiomyopathy (38.1% vs. 29.7%) whereas patients with EF &gt;50% more often had hypertension (40.6% vs. 29.8%), hypertrophic cardiomyopathy (11.5% vs. 0.7%) and congenital heart disease (7.6% vs. 2.7%), all p&gt;0.001. Cardiovascular death was the most common cause of death in all EF categories (about 55%). In a Cox proportional hazard model, patients with EF &gt;50% had hazard ratio (HR) (95% CI) 10.6 (5.71–19.8), those with EF 40–49% 6.83 (4.43–10.5) and patients with EF&lt;40% 7.97 (6.45–9.85) for all-cause mortality (NS). According to the conditional survival analysis patients aged 20, 25, 30, 35 and 40 years with EF&lt;40% lost a median of 28.5, 26.6, 24.7, 22.2 and 20.1 “life years” whereas patients with EF&gt;50% lost 32.3, 28.7, 26.1, 26.3 and 21.6 “life years” as presented in figure 1. Conclusion HF patients &lt;55 years with EF&gt;50% had different coexisting conditions and higher mortality risk, although not significant when compared to patients with EF &lt;40%. Moreover, compared to the general population patients with EF&gt;50% lost more life years than patients with EF&lt;40%. Figure 1 Funding Acknowledgement Type of funding source: None


2021 ◽  
Vol 7 ◽  
Author(s):  
Wilson Matthew Raffaello ◽  
Joshua Henrina ◽  
Ian Huang ◽  
Michael Anthonius Lim ◽  
Leonardo Paskah Suciadi ◽  
...  

Heart failure is currently one of the leading causes of morbidity and mortality. Patients with heart failure often present with acute symptoms and may have a poor prognosis. Recent evidence shows differences in clinical characteristics and outcomes between de novo heart failure (DNHF) and acute decompensated chronic heart failure (ADCHF). Based on a better understanding of the distinct pathophysiology of these two conditions, new strategies may be considered to treat heart failure patients and improve outcomes. In this review, the authors elaborate distinctions regarding the clinical characteristics and outcomes of DNHF and ADCHF and their respective pathophysiology. Future clinical trials of therapies should address the potentially different phenotypes between DNHF and ADCHF if meaningful discoveries are to be made.


2020 ◽  
Vol 359 (6) ◽  
pp. 325-333 ◽  
Author(s):  
Ghulam Murtaza ◽  
Timir K Paul ◽  
Zia Ur Rahman ◽  
Danielle Kelvas ◽  
Steven J. Lavine

2015 ◽  
Vol 2 (3) ◽  
pp. 159-167 ◽  
Author(s):  
Mahmoud Hassanein ◽  
Magdy Abdelhamid ◽  
Bassem Ibrahim ◽  
Ahmed Elshazly ◽  
Mohamed Wafaie Aboleineen ◽  
...  

2004 ◽  
Vol 43 (5) ◽  
pp. A180 ◽  
Author(s):  
Scott Solomon ◽  
Bertil Olofsson ◽  
Peter Finn ◽  
Hicham Skali ◽  
Leonardo Zornoff ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document